Hereditary hemorrhagic telangiectasias (HHT) and various slow-flow malformations (especially venous and lymphatic malformations) are caused by activating mutations of the AKT/mTOR pathway [5]. The gene discussed is MTOR; the disease is hereditary hemorrhagic telangiectasia.